Abstract
Central nervous system (CNS) aspergillosis carries a uniformly poor prognosis in bone marrow transplant recipients. Amphotericin B can be bound to lipid carriers leading to improvement of its therapeutic index. We describe the successful medical management of CNS aspergillosis in an allogeneic bone marrow transplant patient with administration of Amphotericin B Lipid Complex.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Khoury, H., Adkins, D., Miller, G. et al. Resolution of invasive central nervous system aspergillosis in a transplant recipient. Bone Marrow Transplant 20, 179–180 (1997). https://doi.org/10.1038/sj.bmt.1700852
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1700852
Keywords
This article is cited by
-
Cerebral aspergillosis in a patient with leprosy and diabetes: a case report
BMC Research Notes (2014)
-
Central nervous system aspergillosis in allogeneic stem cell transplant recipients
Bone Marrow Transplantation (2003)